Major Williams Political Views, Jake And Hunter Martinez, Chrysler Pacifica Uconnect Theater Not Working, Noel Thompson Lancaster Pa, Articles J

Jonathan Leo, a professor of neuro-anatomy at tiny Lincoln Memorial University in Harrogate, Tenn., posted a letter on the Web site of the British Medical Journal this month criticizing a study that appeared in JAMA last spring. The petition was circulated by the Institute for Antiracism in Medicine, a Chicago advocacy group founded by three Black physicians last year. Meet JAMA's new editor-in-chief: Kirsten Bibbins-Domingo - Advisory All Rights Reserved. JAMA and the JAMA Network represent an unparalleled platform for the very best science to reach the broadest audience and for advancing the discussions, debates and new ideas that will continue to shape health nationally and globally. Your students should be very proud to have you as a teacher and mentor. 3:00 pm March 13, 2009 guests wrote: Perhaps the journal should be renamed the Journal of the American Pharmaceutical Industry. You have For an editor to belittle a physician with ad hominem attacks and yet ignore the substance of his apparently accurate concerns is unconscionable. 2006;296:283-291. ", But such an acknowledgement would undercut the financial interests of all involved. Fostering and leading the development of scholarship published in JAMA Network journals that enhances health equity and dismantles structural racism in medical education, research, clinical care, health policy, and society. How a Study Gets Published in a Medical Journal - Business Insider JAMAis a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. I am confident Dr. Bibbins-Domingowith her remarkable professional background ranging from basic science to an array of scholarly approaches to clinical studieswill effectively advance JAMAs mission that accelerates clinical research into practice at this critical time in health care in the U.S. and in global public health., This is an extraordinary time for science, medicine and public healthone where the possibilities for accelerating advancements in human health seem limitless, while deep challenges to achieving optimal health for all seem intractable, said Dr. Bibbins-Domingo. Published The appointment was met with immediate, widespread support on Twitter, STAT News reports. However, disclosure of the relationship would not have changed the troubling end result: A researcher with a history of being funded by SSRI makers completes a gold-standard federally-funded study of post stroke SSRI use, which is published in one of the most prestigious medical journals in the world, and is given a forum in the national media to tell the general public that anyone who has had a stroke, whether or not they have been diagnosed with depression, should start a prophylactic regimen of Lexapro even though non-medical approaches perform just as well. [1], Unable to find a factual error in the analysis by Leo and Lacasse, these JAMA editors resorted to ad hominem attacks, by calling Leo a nobody and a nothing.. 5:02 pm March 13, 2009 WSJ Fan wrote: How arrogant does one have to be to refer to another person as a nobody? Im grateful for having had the privilege to serve as editor of JAMA for ten years and to build a substantial foundation for the future. Leo says he received an angry call from JAMA executive deputy editor Phil Fontanarosa last week, shortly after Leos article was published on the BMJ Web site. This physician was simply drawing attention to something the AMA has railed against for a long time (i.e. Bauchner, who led the journal since 2011, had been on administrative leave since March while a review of the podcast and the tweet were in process, the AMA said. So, the authors spun the conclusion by ignoring their own findings. Top JAMA editor steps down after colleague questioned whether - CNN